Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 1
2018 1
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.
He Y, Davies CM, Harrington BS, Hellmers L, Sheng Y, Broomfield A, McGann T, Bastick K, Zhong L, Wu A, Maresh G, McChesney S, Yau Wong K, Adams MN, Sullivan RC, Palmer JS, Burke LJ, Ewing AD, Zhang X, Margolin D, Li L, Lourie R, Matsika A, Srinivasan B, McGuckin MA, Lumley JW, Hooper JD. He Y, et al. Among authors: harrington bs. Oncogene. 2020 Jan;39(1):219-233. doi: 10.1038/s41388-019-0983-3. Epub 2019 Aug 30. Oncogene. 2020. PMID: 31471585
NF-κB Signaling in Ovarian Cancer.
Harrington BS, Annunziata CM. Harrington BS, et al. Cancers (Basel). 2019 Aug 15;11(8):1182. doi: 10.3390/cancers11081182. Cancers (Basel). 2019. PMID: 31443240 Free PMC article. Review.
Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.
He Y, Reid JC, He H, Harrington BS, Finlayson B, Khan T, Hooper JD. He Y, et al. Among authors: harrington bs. Biol Chem. 2018 Sep 25;399(9):1091-1097. doi: 10.1515/hsz-2017-0308. Biol Chem. 2018. PMID: 29447112
Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases.
Dong Y, Harrington BS, Adams MN, Wortmann A, Stephenson SA, Lisle J, Herington A, Hooper JD, Clements JA. Dong Y, et al. Among authors: harrington bs. Biol Chem. 2014 Sep;395(9):977-90. doi: 10.1515/hsz-2014-0147. Biol Chem. 2014. PMID: 24854540 Review.
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Harrington BS, He Y, Khan T, Puttick S, Conroy PJ, Kryza T, Cuda T, Sokolowski KA, Tse BW, Robbins KK, Arachchige BJ, Stehbens SJ, Pollock PM, Reed S, Weroha SJ, Haluska P, Salomon C, Lourie R, Perrin LC, Law RHP, Whisstock JC, Hooper JD. Harrington BS, et al. Theranostics. 2020 Jan 12;10(5):2095-2114. doi: 10.7150/thno.30736. eCollection 2020. Theranostics. 2020. PMID: 32104500 Free PMC article.
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD. Harrington BS, et al. Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4. Br J Cancer. 2016. PMID: 26882065 Free PMC article.
CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC, He Y, Broomfield A, Paatan NJ, Harrington BS, Tseng HW, Beaven EA, Kiernan DM, Swindle P, Clubb AB, Levesque JP, Winkler IG, Ling MT, Srinivasan B, Hooper JD, Pettit AR. Wu AC, et al. Among authors: harrington bs. J Pathol. 2016 Jun;239(2):218-30. doi: 10.1002/path.4718. Epub 2016 Apr 27. J Pathol. 2016. PMID: 27174786
New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways.
He Y, Harrington BS, Hooper JD. He Y, et al. Among authors: harrington bs. Oncoscience. 2016 Jan 29;3(1):5-8. doi: 10.18632/oncoscience.286. eCollection 2016. Oncoscience. 2016. PMID: 26973855 Free PMC article.
Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model.
Harrington BS, Ozaki MK, Caminear MW, Hernandez LF, Jordan E, Kalinowski NJ, Goldlust IS, Guha R, Ferrer M, Thomas C, Shetty J, Tran B, Wong N, House CD, Annunziata CM. Harrington BS, et al. Cancers (Basel). 2020 Jun 21;12(6):1645. doi: 10.3390/cancers12061645. Cancers (Basel). 2020. PMID: 32575908 Free PMC article.
Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens.
Chen Y, Harrington BS, Lau KCN, Burke LJ, He Y, Iconomou M, Palmer JS, Meade B, Lumley JW, Hooper JD. Chen Y, et al. Among authors: harrington bs. J Pharm Biomed Anal. 2017 May 30;139:65-72. doi: 10.1016/j.jpba.2017.02.047. Epub 2017 Feb 28. J Pharm Biomed Anal. 2017. PMID: 28279929
11 results
Jump to page
Feedback